Drug reference
hyaluronate
Viscoelastic substance · Ophthalmic surgical agent
Viscoelastic substanceOphthalmic surgical agent
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Not yet extracted
Indications
assist in ocular surgery by maintaining spaces, moving tissue, and protecting surfaces
Side effects
Common
transient elevation of IOP after surgery
Related guidelines
Substance use disorders
NIMHANS · Psychiatry · 2022
Preoperative cardiac evaluation for non-cardiac surgery
AHA · Cardiology · 2025
Skin and soft tissue infections
IDSA · Infectious Diseases · 2010
Postpartum haemorrhage
FOGSI · Obstetrics & Gynaecology · 2024
Benign prostatic hyperplasia
EAU · Urology · 2024
Other Viscoelastic substance drugs
Ask House about hyaluronate
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team